These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10199158)

  • 21. Insulin lispro improves postprandial glucose control in patients with diabetes mellitus.
    Skrha J; Smahelová A; Andĕl M; Vrtovec M; Subić J; Kreze A; Vozar J; Korecová M; de Verga V; Wyatt J; Metcalfe S; Ristić S
    Sb Lek; 2002; 103(1):15-21. PubMed ID: 12448933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp.
    Heinemann L; Weyer C; Rave K; Stiefelhagen O; Rauhaus M; Heise T
    Exp Clin Endocrinol Diabetes; 1997; 105(3):140-4. PubMed ID: 9228509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in the treatment of diabetes-insulin analogues.
    Vajo Z; Duckworth WC
    Minerva Endocrinol; 2002 Sep; 27(3):167-80. PubMed ID: 12091792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiological insulin replacement in type 1 diabetes mellitus.
    Bolli GB
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S317-32. PubMed ID: 11460580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.
    Schwartz S; Zagar AJ; Althouse SK; Pinaire JA; Holcombe JH
    Clin Ther; 2006 Oct; 28(10):1649-57. PubMed ID: 17157120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The human insulin analogue insulin lispro.
    Koivisto VA
    Ann Med; 1998 Jun; 30(3):260-6. PubMed ID: 9677011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recent trends of development of rapid-acting and long-acting human insulin analogues--its biological characteristics and clinical availability].
    Yokono K
    Nihon Rinsho; 2001 Nov; 59(11):2127-33. PubMed ID: 11712396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are presently available insulin analogues clinically beneficial?
    Berger M; Heinemann L
    Diabetologia; 1997 Jul; 40 Suppl 2():S91-6. PubMed ID: 9248708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin analogues and management of diabetes mellitus.
    Vaidyanathan B; Menon PS
    Indian J Pediatr; 2000 Jun; 67(6):435-41. PubMed ID: 10932964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Present and future of insulin treatment].
    Skrha J
    Vnitr Lek; 2013 Mar; 59(3):209-13. PubMed ID: 23713190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin analogues.
    Heller SR
    Curr Med Res Opin; 2002; 18 Suppl 1():s40-7. PubMed ID: 12365818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin aspart: a new rapid-acting insulin analog.
    Setter SM; Corbett CF; Campbell RK; White JR
    Ann Pharmacother; 2000 Dec; 34(12):1423-31. PubMed ID: 11144701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of [Lys(B28), Pro(B29)]-human insulin in patients with diabetes mellitus.
    Akalin S; Erbas T; Yilmaz MT; Ilkova H; Satman I; Ersanli Z; Karsidag K; Damci T; Bagriacik N
    Isr J Med Sci; 1997 Nov; 33(11):716-9. PubMed ID: 9434806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin.
    Howey DC; Bowsher RR; Brunelle RL; Woodworth JR
    Diabetes; 1994 Mar; 43(3):396-402. PubMed ID: 8314011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Insulin therapy-new insulin analogues].
    Ehren M; Klein HH
    Internist (Berl); 2019 Sep; 60(9):887-894. PubMed ID: 31396651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 pro --> Asp insulin analogues.
    Whittingham JL; Edwards DJ; Antson AA; Clarkson JM; Dodson GG
    Biochemistry; 1998 Aug; 37(33):11516-23. PubMed ID: 9708987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid and long-acting analogues as an approach to improve insulin therapy: an evidence-based medicine assessment.
    Heise T; Heinemann L
    Curr Pharm Des; 2001 Sep; 7(14):1303-25. PubMed ID: 11472271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monomeric insulins and their experimental and clinical implications.
    Brange J; Owens DR; Kang S; Vølund A
    Diabetes Care; 1990 Sep; 13(9):923-54. PubMed ID: 2226110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Getting closer to physiologic insulin secretion.
    Heise T
    Clin Ther; 2007; 29 Suppl D():S161-5. PubMed ID: 18191068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Glycemic control and new prospects on insulinotherapy in diabetes mellitus type 1].
    Hernáez Rodríguez R; Conget Donlo I
    Rev Clin Esp; 2005 Jun; 205(6):290-6. PubMed ID: 15970139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.